Share on LinkedInShare on LinkedIn

ARTICLE · 12 JULY 2011

Therasense Decision Raises Bar For Proving Inequitable Conduct

On May 25, in Therasense Inc. v. Becton, Dickinson, & Co., No. 08-1511, the en banc U.S. Court of Appeals for the Federal Circuit raised the bar for proving inequitable conduct in patent actions.

United StatesIntellectual Property

On May 25, in Therasense Inc. v. Becton, Dickinson, & Co., No. 08-1511, the en banc U.S. Court of Appeals for the Federal Circuit raised the bar for proving inequitable conduct in patent actions.

The inequitable conduct defense allows accused patent infringers to render a patent unenforceable where they demonstrate that the patentee misrepresented or concealed material information with the specific intent to deceive the PTO as to any single claim. Accused infringers have long been required to demonstrate both materiality and deceptive intent by clear and convincing evidence. However, there has been conflict and confusion concerning the appropriate definition of material and the standards for inferring deceptive intent from circumstantial evidence.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from